New Zealand Society for the Study of Diabetes (NZSSD) is hosting a series of webinars for the benefit of primary care. The next session will focus on Continuous glucose monitoring in primary care on 1 April, 6-8pm (date was originally 18 March) and hosted by the Technology in Diabetes SIG.
This session will present an overview of CGM, including a review of CGM available in NZ and their application as a management tool for type 2 diabetes.
Register here by 10pm, Tuesday 31 March, 2026.
Note: if you registered for 18 March, you do not need to re-register for 1 April.
Note: Past webinars are available in the member section of the NZSSD website. Once you are logged in, select the 'Resources' tab and scroll down to 'Other'' at the bottom of the list. Click on the 'Meetings and Webinar Resources' link to view a list of webinars available.
Kathy joined Pinnacle earlier this month as clinical diabetes specialist for Waikato, replacing the role previously held by Anne Waterman.
Read moreFrom 1 December 2025, Pharmac will remove Special Authority renewal requirements for several treatments, including insulin pump consumables, continuous glucose monitors, LAMA/LABA inhalers, epoetin alfa, budesonide capsules, and febuxostat.
Read moreFunding for patients who require a follow-up appointment following HbA1c retest by Awanui Labs.
This funding ends on 28 February 2026
A guide for clinical management of type 2 diabetes, to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.